Skip to main navigation Skip to search Skip to main content

A Prospective, Randomized, Multi-Center Double-Blind Study of EArly Corticosteriod Cessation vs. Long Term Maintenance Corticosteroid Therapy with Prograf and CellCept in Primary Renal Transplant Recipients

Project: Research

Project Details

StatusFinished
Effective start/end date05/16/02 → 03/31/09

Funding

  • Astellas Pharma US Incorporated: $84,016.86